Comparative Trial of the Effects on Glucose Tolerance and Lipoprotein Metabolism of two New Oral Contraceptives Containing Gestoden and Desogestrel

References

• Waine H, Frieden E H, Caplan H I, Cole T. Metabolic effects of Enovid in rheumatoid patients. Arthritis Rheum 1965; 6: 796
   Google Scholar
• Kalkhoff R K. Effect of oral contraceptive agents on carbohydrate metabolism. J Steroid Biochem 1975; 6: 949–56
   PubMedGoogle Scholar
• Wynn V. Effects of duration of low-dose oral contraceptive administration on carbohydrate metabolism. Am J Obstet Gynecol 1982; 142: 739–46
   PubMed Web of Science ®Google Scholar
• Spellacy W N. Carbohydrate metabolism during treatment with estrogens, progestogen, and low-dose oral contraceptives. AmJ Obstet Gynecol 1982; 142: 732–4
   Google Scholar
• Wynn V, Adams P W, Godsland I, et al. Comparison of effects of different combined oral-contraceptives formulations on carbohydrate and lipid metabolism. Lancet 1979, i: 1045–9
   Google Scholar
• Arntzenius A C, van Gent C M, Van der Voort H, Stegerhoek C I, Styblo K. Reduced high-density lipoprotein in women aged 40–41 using oral contraceptives. Lancet 1978, i: 1221–3
   Google Scholar
• Wallace R B, Hoover J, Barret-Connor E, et al. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Lancet 1979, ii: 111–5
   Google Scholar
• Fotherby K. Oral contraceptives, lipids and cardiovascular disease. Contraception 1985; 31: 367–94
   PubMed Web of Science ®Google Scholar
• Kay C R. The Royal College of General Practitioners oral contraception study: Some recent observations. Clin Obstet Gynaecol 1984; 11: 759–86
   PubMedGoogle Scholar
• Larsson-Cohn U, Fahreus L, Wallentin L, Zador G. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril 1981; 35: 172–9
   PubMed Web of Science ®Google Scholar
• Dolhofer R, Weiss L, Wieland O H. Experience with the glucosedehydrogenase-UV method for the determination or blood glucose. J Clin Chem Clin Biochem 1976; 14: 415–7
   PubMedGoogle Scholar
• Kühl C. Glucose metabolism during and after pregnancy in normal and gestational diabetic women. I. Acta Endocrinol 1975; 79: 709–19
   PubMedGoogle Scholar
• Dash R J, England B J, Midgley A R, Jr, Niswender G D. A specific non-chromatographic radioimmunoassay for human plasma cortisol Steroids. 1975; 26: 647–61
   Google Scholar
• Friedwald W T, Levy R I, Frederickson D S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Hertz J B, Johnsen S G. Sex-hormone-binding globulin (SHBG) in serum in threatened abortion. Acta Endocrinol 1983; 104: 381–4
   Google Scholar
• Gaspard U J, Romus M A, Luyckx A S. Carbohydrate metabolism alterations with monophasic, sequential and triphasic oral contraceptives containing ethinyl oestradiol plus levonorgestrel or desogestrel. Advances in fertility control and the treatment of sterility, R Rolland. MTP Press Limited, The Hague, Dordrecht, Lancaster, Boston 1983; 107–11
   Google Scholar
• De Pirro R, Forte F, Bertoli E, Greco A V, Lauro R. Changes in insulin receptors during oral contraception. J Clin Endocrinol Metab 1981; 52: 29–33
   PubMed Web of Science ®Google Scholar
• Skouby S O, Andersen O, Saurbrey N, Kuhl C. Oral contraception and insulin sensitivity: In vivo assessment in normal women and in women with previous gestational diabetes. J Clin Endocrinol Metab 1987; 64: 519–23
   PubMed Web of Science ®Google Scholar
• Munck A. Glucocorticoid inhibition of glucose uptake by peripheral tissues: Old and new evidence, molecular mechanisms and physiological significance. Perspect Biol Med 1971; 14: 265–89
   PubMed Web of Science ®Google Scholar
• Gordon T, Castelli W P, Hjortland M C, Kannel W B, Dawber T R. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977; 62: 707–14
   PubMed Web of Science ®Google Scholar
• Kuusi T, Nikkala E A, Tikkanen M J, Sipinen S. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein. Atherosclerosis 1985; 54: 251–62
   PubMed Web of Science ®Google Scholar
• Tikkanen M J, Nikkala E A, Kuusi T, Sipinen S. Effects of oestradiol and levenorgestrel on lipoprotein, lipids and postheparin plasma lipase activities in normolipopro-teinaemic women. Acta Endocrinol 1982; 99: 630–5
   Google Scholar
• Cullberg G, Dovre P A, Lindstedt G, Steffensen K. On the use of plasma proteins as indicators of the metabolic effects of combined oral contraceptives. Acta Obstet Gynecol Scand 1982; 47–54, Suppl 111
   Google Scholar